The HAB Pharma & Research Limited represents a firm in the domestic medicinal landscape. Created in the late 1940s, here it has cultivated a strong image for producing high-quality affordable drugs and persistently participates in significant development to improve individual outcomes. The company's portfolio comprises a wide range of clinical segm